Skip to content

PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men

PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07263048
Enrollment
800
Registered
2025-12-04
Start date
2026-10-30
Completion date
2029-10-01
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Prevention, Latino Men Who Have Sex With Men, Pharmacy

Brief summary

This type 3 Hybrid Effectiveness-Implementation study will evaluate PrEP & Soccer, a multicomponent and multilevel implementation strategy delivered by a pharmacy chain to increase PrEP knowledge and initial PrEP appointment attendance among men. Using mixed methods and implementation science approaches, this parallel cluster randomized controlled study will assess key implementation factors at CVS Health pharmacy locations assigned either to the PrEP & Soccer intervention or to a general CVS Health service information-only control.

Interventions

BEHAVIORALPrEP & Soccer PrEP Navigation

Pharmacies assigned to this group will receive personalized PrEP navigation support provided by a PrEP Navigator following baseline assessment. Sessions may be brief (\~15 minutes) or longer depending on participant needs. The navigator supplies a pamphlet describing PrEP (how it works, payment options), and CVS-provided HIV services; discusses whether PrEP or another HIV prevention strategy is best for the participant; and, if PrEP is selected, provides a referral to a PrEP provider.

BEHAVIORALCVS Health brochure

Standard health information delivered via brochure, no active navigation components. Content includes a brochure describing services offered by CVS Health and the MinuteClinic.

Sponsors

University of Miami
Lead SponsorOTHER
National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

8 pharmacies randomized 1:1

Eligibility

Sex/Gender
MALE
Age
18 Years to 54 Years
Healthy volunteers
No

Inclusion criteria

* Provide their informed consent to participate. * Demonstrate willingness to comply with all study procedures and be available for the study duration. * Ages 18 to 54 years of age. * A man. * Self-report any of the following behaviors and/or health conditions 1. Diagnosed with bacterial sexually transmitted infection (e.g., syphilis, gonorrhea, or chlamydia) 2. Sex with a partner who is living with HIV 3. Sex without a condom with two or more partners whose HIV status were unknown 4. Injection drug use and sharing injection equipment * Have been without a PrEP prescription for at least 24 weeks.

Exclusion criteria

* Diminished capacity to consent due to: 1. Inability to provide informed consent (e.g., cognitive impairment), or 2. Presence of severe psychiatric symptoms (e.g., mania, psychosis) that impair the ability to provide informed consent, as assessed by interviewers trained in CITI Human Subjects Research and NIH Good Clinical Practice. * Younger than 18 or older than 54 years of age. * A woman. * Does not self-report any of the following behaviors and/or health conditions 1. Diagnosed with bacterial sexually transmitted infection (e.g., syphilis, gonorrhea, or chlamydia) 2. Sex with a partner who is living with HIV 3. Sex without a condom with two or more partners whose HIV status were unknown 4. Injection drug use and sharing injection equipment * Has had an active PrEP prescription within the past 24 weeks. * Living with HIV (e.g. has received an HIV diagnosis). * Planning to move outside of Miami-Dade or Broward counties in the next 7 months.

Design outcomes

Primary

MeasureTime frameDescription
Self-report attendance at first PrEP appointmentBaseline, 3 months, and 6 monthsAttendance at the first scheduled PrEP (pre-exposure prophylaxis) appointment will be assessed using self-report responses at baseline, 3 months, and 6 months. Participants will respond to the question: "Did you attend your first scheduled PrEP appointment?" with binary options (Yes/No). This will be measured by the percentage of participants responding "Yes" at each time point and will evaluate engagement with PrEP services over time.

Secondary

MeasureTime frameDescription
PrEP Cascade Questionnaire, measured by participant survey responsesBaseline, 3 months, and 6 monthsThe PrEP Cascade Questionnaire is a structured survey designed to assess participant engagement across stages of the PrEP prevention cascade (awareness, access, initiation, adherence, and retention). Each item will be scored as binary (Yes/No) or categorical (e.g., aware/not aware, initiated/not initiated, adherent/non-adherent). This will be measured by the percentage of participants meeting each cascade stage at each time point and will evaluate the progression through the PrEP cascade over time.
Percentage of correct PrEP questions, measured by participant survey responsesBaseline, 3 months, and 6 months.The PrEP Questionnaires is a structured survey designed to assess participant PrEP knowledge. Each item will be scored as binary (Yes/No) or categorical. This will be measured by the percentage of correct responses at each time point and will evaluate PrEP knowledge over time.

Countries

United States

Contacts

CONTACTMaria R Velazquez, MPA
mrvelazquez@med.miami.edu305-243-1946
PRINCIPAL_INVESTIGATORMariano R Kanamori, PhD

University of Miami

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026